Society ❯ Public Health ❯ Chronic Diseases

Obesity

Diabetes Health Risks Health Access Weight Loss Drugs Diabetes Management Treatment Accessibility Health Policy Diabetes Mellitus Health Interventions Diet and Lifestyle Heart Disease Impact of Obesity on Health Inflammation Diet-Related Issues Cardiovascular Health Youth Fitness Cancer Prevention Patient Access to Treatment Access to Medicines Health Insurance Health Disparities Advocacy Groups

FDA Proposes Blocking Bulk Compounding of GLP-1 Drugs by Outsourcing Facilities

The move signals the agency sees no clinical need for bulk versions given improved supply.

Meta-Analysis Finds GLP-1 Drugs Show Little Short-Term Impact on Obesity-Linked Cancer Risk

Blog Jobs Terms of Service Privacy Policy Cookies Help Partners About Us Copyright © 2026 Mina Labs, Inc.

We value your privacy

We and our partners use cookies and similar technologies to understand how you use our site and to show you personalized advertisements on other platforms. By clicking "Accept All," you consent to these technologies for advertising, analytics and retargeting. Click "Decline All" to opt out of non-essential cookies. You can learn more in our Privacy Policy.